Biogen Inc Aducanumab Webinar Update Transcript - Thomson StreetEvents

Biogen Inc Aducanumab Webinar Update Transcript

Biogen Inc Aducanumab Webinar Update Transcript - Thomson StreetEvents
Biogen Inc Aducanumab Webinar Update Transcript
Published Feb 23, 2021
17 pages (11815 words) — Published Feb 23, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of BIIB.OQ conference call or presentation 23-Feb-21 7:00pm GMT

  
Brief Excerpt:

...John Dwyer Allow me to welcome, everyone, to this very important presentation by our colleagues from Biogen. This is John Dwyer, President of the Global Alzheimer's Platform Foundation. This was initially intended as a discussion of the science and clinical aspects of Biogen's drug aducanumab, and we broadened it to the public, which I think is terrific. So let me just say a word about who GAP is for those of you on this call that don't know us. The Global Alzheimer's Platform Foundation's mission is to reduce the duration and cost and improve the quality of Alzheimer's disease clinical therapeutic studies. Not a trivial mission, to say the least. Over the last 6 years, we have combined with our network of over 80 truly leading clinical trial sites in North America to try and accelerate and improve clinical trials for a variety of different Alzheimer's therapies. We're proud to say one of those was Biogen's. And it is with that background that we have in our audience, all of our sites,...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Biogen Inc
Ticker
BIIB.OQ
Time
7:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Biogen Inc Evaluation Of Aducanumab Efficacy And Safety In Early Alzheimer's Disease Discussion at AD/PD Conference Call Transcript – 2021-03-13 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 13-Mar-21 11:45am GMT

Biogen Inc Evaluation of aducanumab safety in early Alzheimer’s disease at AD/PD Transcript – 2021-03-13 – US$ 54.00 – Edited Transcript of BIIB.OQ corporate analyst meeting</ 13-Mar-21 12:00pm GMT

Biogen Inc Pre-Recorded Presentation of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD Transcript – 2021-03-10 – US$ 54.00 – Edited Transcript of BIIB.OQ corporate analyst meeting</ 10-Mar-21 11:45am GMT

Biogen Inc Live Discussion of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD Transcript – 2021-03-10 – US$ 54.00 – Edited Transcript of BIIB.OQ corporate analyst meeting</ 10-Mar-21 4:00pm GMT

Biogen Inc at Cowen Healthcare Conference (Virtual) Transcript – 2021-03-01 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 1-Mar-21 3:20pm GMT

Biogen Inc Q4 2020 Earnings Call Summary – 2021-02-03 – US$ 54.00 – Edited Brief of BIIB.OQ earnings conference call or presentation 3-Feb-21 1:00pm GMT

Biogen Inc Q4 2020 Earnings Call Transcript – 2021-02-03 – US$ 54.00 – Edited Transcript of BIIB.OQ earnings conference call or presentation 3-Feb-21 1:00pm GMT

Biogen Inc Corporate Call Summary – 2021-01-14 – US$ 54.00 – Edited Brief of BIIB.OQ conference call or presentation 14-Jan-21 2:00pm GMT

Biogen Inc Corporate Call Transcript – 2021-01-14 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 14-Jan-21 2:00pm GMT

Biogen Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-11 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 11-Jan-21 3:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Biogen Inc Aducanumab Webinar Update Transcript" Feb 23, 2021. Alacra Store. May 23, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Biogen-Inc-Aducanumab-Webinar-Update-T13659742>
  
APA:
Thomson StreetEvents. (2021). Biogen Inc Aducanumab Webinar Update Transcript Feb 23, 2021. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Biogen-Inc-Aducanumab-Webinar-Update-T13659742>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.